Marc A Dall'Era

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint The economics of active surveillance for prostate cancer
    Marc A Dall'Era
    Department of Urology, University of California, Sacramento, California, USA
    Curr Opin Urol 23:278-82. 2013
  2. doi request reprint Active surveillance for prostate cancer: a systematic review of the literature
    Marc A Dall'Era
    Department of Urology, University of California Davis Medical Center, Sacramento, CA 95817, USA
    Eur Urol 62:976-83. 2012
  3. pmc Contemporary management of muscle-invasive bladder cancer
    Marc A Dall'Era
    Department of Urology, University of California Davis, 4860 Y Street, Suite 3500, Sacramento, CA 95817, USA
    Expert Rev Anticancer Ther 12:941-50. 2012
  4. doi request reprint Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment
    Marc A Dall'Era
    Department of Urology, University of California, Davis, Sacramento, CA 95817, USA
    BJU Int 107:1232-7. 2011
  5. doi request reprint Active surveillance for early-stage prostate cancer: review of the current literature
    Marc A Dall'Era
    Department of Urology, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
    Cancer 112:1650-9. 2008
  6. doi request reprint Economic analysis of active surveillance for localized prostate cancer
    Sun Kim
    Department of Urology, School of Medicine, University of California, Davis, California, USA
    Curr Opin Urol 22:247-53. 2012
  7. doi request reprint Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Marc A Dall'Era
    Department of Urology, University of California, San Francisco, CA 94143 1695, USA
    Nat Clin Pract Urol 5:277-83. 2008
  8. ncbi request reprint HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells
    Marc A Dall'Era
    Department of Urology, University of Washington, Seattle, Washington, USA
    Prostate 67:714-21. 2007
  9. doi request reprint Active surveillance for localized prostate cancer--current practices and recommendations
    Jennifer N Wu
    Department of Urology, University of California, Davis Medical Center, Sacramento, CA, USA
    ScientificWorldJournal 10:2352-61. 2010
  10. doi request reprint Outcomes and follow-up strategies for patients on active surveillance
    Marc A Dall'Era
    Department of Urology, University of California, Davis, CA, USA
    Curr Opin Urol 19:258-62. 2009

Detail Information

Publications14

  1. doi request reprint The economics of active surveillance for prostate cancer
    Marc A Dall'Era
    Department of Urology, University of California, Sacramento, California, USA
    Curr Opin Urol 23:278-82. 2013
    ..To review the economics of managing low-risk prostate cancer with active surveillance compared with other standard therapies...
  2. doi request reprint Active surveillance for prostate cancer: a systematic review of the literature
    Marc A Dall'Era
    Department of Urology, University of California Davis Medical Center, Sacramento, CA 95817, USA
    Eur Urol 62:976-83. 2012
    ..Prostate cancer (PCa) remains an increasingly common malignancy worldwide. The optimal management of clinically localized, early-stage disease remains unknown, and profound quality of life issues surround PCa interventions...
  3. pmc Contemporary management of muscle-invasive bladder cancer
    Marc A Dall'Era
    Department of Urology, University of California Davis, 4860 Y Street, Suite 3500, Sacramento, CA 95817, USA
    Expert Rev Anticancer Ther 12:941-50. 2012
    ..Personalized chemotherapy is currently being actively pursued to target the underlying molecular changes and tailor to individual needs...
  4. doi request reprint Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment
    Marc A Dall'Era
    Department of Urology, University of California, Davis, Sacramento, CA 95817, USA
    BJU Int 107:1232-7. 2011
    ....
  5. doi request reprint Active surveillance for early-stage prostate cancer: review of the current literature
    Marc A Dall'Era
    Department of Urology, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
    Cancer 112:1650-9. 2008
    ..The best candidates for active surveillance are being defined, as are predictors of active treatment. The psychosocial ramifications of surveillance for prostate cancer can be profound and future needs and unmet goals will be discussed...
  6. doi request reprint Economic analysis of active surveillance for localized prostate cancer
    Sun Kim
    Department of Urology, School of Medicine, University of California, Davis, California, USA
    Curr Opin Urol 22:247-53. 2012
    ..The purpose of this review is to analyze the economics of active surveillance in comparison with other therapies...
  7. doi request reprint Active surveillance for low-risk prostate cancer: selection of patients and predictors of progression
    Marc A Dall'Era
    Department of Urology, University of California, San Francisco, CA 94143 1695, USA
    Nat Clin Pract Urol 5:277-83. 2008
    ..The psychosocial impact of active surveillance on patients is discussed as well as contemporary methods for disease monitoring...
  8. ncbi request reprint HSP27 and HSP70 interact with CD10 in C4-2 prostate cancer cells
    Marc A Dall'Era
    Department of Urology, University of Washington, Seattle, Washington, USA
    Prostate 67:714-21. 2007
    ..In this study, we compared CD10 mRNA and protein expression between benign and malignant prostate cells and employed proteomic analysis to identify proteins that interact with CD10 in C4-2 prostate cancer cells...
  9. doi request reprint Active surveillance for localized prostate cancer--current practices and recommendations
    Jennifer N Wu
    Department of Urology, University of California, Davis Medical Center, Sacramento, CA, USA
    ScientificWorldJournal 10:2352-61. 2010
    ..Ongoing clinical trials with watchful waiting and active surveillance for prostate cancer will ultimately provide improved evidence for managing early, localized disease...
  10. doi request reprint Outcomes and follow-up strategies for patients on active surveillance
    Marc A Dall'Era
    Department of Urology, University of California, Davis, CA, USA
    Curr Opin Urol 19:258-62. 2009
    ..This approach allows one to limit prostate cancer treatment and any risk of related morbidity to the men who will benefit the most from active intervention...
  11. doi request reprint Sociodemographic predictors of prostate cancer risk category at diagnosis: unique patterns of significant and insignificant disease
    Marc A Dall'Era
    Urologic Outcomes Research Group, Department of Urology, University of California San Francisco, San Francisco, California, USA
    J Urol 181:1622-7; discussion 1627. 2009
    ..We determined various sociodemographic predictors of prostate cancer risk category at presentation as assessed by serum prostate specific antigen, cancer grade and tumor stage...
  12. ncbi request reprint Watchful waiting versus active surveillance: appropriate patient selection
    Marc A Dall'Era
    Division of Urology, University of California, San Diego, UCSD Medical Center, 200 West Arbor Drive 8897, San Diego, CA 92103, USA
    Curr Urol Rep 9:211-6. 2008
    ..Finally, we support well-designed prospective clinical trials that evaluate active surveillance compared with immediate definitive treatment...
  13. ncbi request reprint Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer
    Thomas J Walsh
    Department of Urology, University of California San Francisco, San Francisco, California 94143 1695, USA
    J Urol 178:1440-6; discussion 1446. 2007
    ..We hypothesize that early orchiopexy is protective against subsequent development of testicular germ cell cancer...
  14. pmc Differential expression of CD10 in prostate cancer and its clinical implication
    Marc A Dall'Era
    Department of Urology, University of Washington, Seattle, WA, USA
    BMC Urol 7:3. 2007
    ..We hypothesize that prostate tumors expressing high levels of CD10 have a more aggressive biology with an early propensity towards lymph node metastasis...